14 Documents disponibles dans la collection
At a time of increased debate on the laws controlling the use of cannabis in the European Union, this report answers some of the questions most often asked about cannabis legislation. Using a question and answer format, basic definitions and the[...]
FRANÇAIS : Entre mars et mai 2021, le projet EU4Monitoring Drugs (EU4MD) a permis de cartographier les systèmes nationaux de prévention dans les pays de la zone de la politique européenne de voisinage (PEV). Cette note d'information décrit la [...]
The result of the EMCDDA's cooperation with countries in the Western Balkans over many years, this report is the first of its kind. It gives insight into the drug-related problems faced by six countries in the region, through the available data [...]
This report is a rapid and preliminary analysis of the impact of COVID-19 on selected online markets. Three relatively large darknet markets were reviewed for the purposes of this study, selected because of their importance to the EU market and [...]
Since the beginning of 2020, the world has been experiencing an unprecedented public health emergency caused by the coronavirus disease (COVID-19) pandemic, which has led to the progressive introduction of social distancing and other control mea[...]
FRANÇAIS : Depuis le début de l'année 2020, le monde connaît une situation sanitaire sans précédent causée par la pandémie de coronavirus (COVID-19), qui a conduit à l'introduction progressive de mesures de distanciation sociale et d'autres mes[...]
Since the start of 2020, European countries have been experiencing an unprecedented public health threat with the emergence of the coronavirus disease (COVID-19). In order to investigate the effects and implications of this outbreak for drug ser[...]
Since the start of 2020, European countries have been experiencing an unprecedented public health threat with the emergence of the coronavirus disease (COVID-19). In order to investigate the effects and implications of this pandemic for people w[...]
This paper provides an analysis of the available data that suggest that a methamphetamine industry is rapidly being established in Afghanistan. The analysis provided is based on information from key informants, documentary sources and the analys[...]
The aim of this 'quick guide' is to make practical information on prevention quality standards available outside the European Union. A condensed version of EMCDDA Manual 7, it includes a description of the eight stages involved in the drug preve[...]
OEDT = EMCDDA ; A. PIRONA ; L. MONTANARI ; I. GIRAUDON ; J. MATIAS ; K. OIEN ; L. VANDAM ; T. SURMONT ; B. GUARITA ; F. MATHIS ; J. MOUNTENEY ; K. NATONIEWSKA ; S. SLEIMAN ; P. GRIFFITHS | 2021
RapportSince early 2020, the COVID-19 pandemic has had a dramatic impact on the way we live, with European countries having to introduce unprecedented measures to protect public health. As with all areas of life, drug consumption, related harms and dru[...]
The open sale of cannabis products in Europe has raised concerns among policymakers, both with regard to the legal status of these products and their potential for harm. The products are marketed for their low THC (tetrahydrocannabinol) content,[...]
This report examines the relatively recent emergence of methamphetamine production in Afghanistan and identifies actions that may be taken in Europe to mitigate the risks. The publication stresses the importance of increasing awareness on the is[...]
This report highlights the responses taken by the EMCDDA's Reitox network of national focal points to the COVID-19 crisis and describes the challenges met by the organisations and the strategies produced to overcome these challenges.
Historique
